Oxidative Stress Markers and Severity of Obstructive Sleep Apnea
Authors:
- 27 September 2019
- book chapter
- Published by Springer Nature
- Vol. 1222, 27-35
Abstract
Oxidative stress underlies both obstructive sleep apnea (OSA) and atherosclerosis. The aim of the study was to assess the markers of oxidative stress in plasma at different stages of OSA in non-smoking obese Caucasian males aged 41–60, with normal oral glucose tolerance test. All patients were subjected to clinical and polysomnographic examinations. The stage of OSA severity was set according to the following criteria of the apnea-hypopnea index (AHI): AHI < 5/h – no disease (OSA-0; n = 26), AHI 5–15/h – mild disease (OSA-1; n = 26), AHI 16–30/h – moderate disease (OSA-2: n = 27), and AHI > 30/h obstructive episodes per hour – severe disease (OSA-3; n = 27). Plasma total antioxidant status (TAS) and thiobarbituric acid-reacting substances (TBARS), reflecting the level of lipid peroxides, were determined spectrophotometrically. We found that TAS decreased and TBARS increased significantly from OSA-0 to OSA-3. We conclude that the oxidative stress markers are conducive to setting the severity of OSA in normoglycemic patients.Keywords
This publication has 19 references indexed in Scilit:
- Cognition and biomarkers of oxidative stress in obstructive sleep apneaClinics, 2013
- Molecular mechanisms of cardiovascular disease in OSAHS: the oxidative stress linkEuropean Respiratory Journal, 2009
- Sleep Apnea and Cardiovascular DiseaseJACC, 2008
- Metabolic effects of the obstructive sleep apnea syndrome and cardiovascular riskArchives of Physiology and Biochemistry, 2008
- Antioxidant status in patients with sleep apnoea and impact of continuous positive airway pressure treatmentEuropean Respiratory Journal, 2006
- Oxidative stress in obstructive sleep apnoeaEuropean Heart Journal, 2005
- Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational studyThe Lancet, 2005
- Circulating cardiovascular risk factors in obstructive sleep apnoea: data from randomised controlled trialsThorax, 2004
- Oxidative Stress and Cardiovascular InjuryCirculation, 2003
- Abnormal lipid peroxidation in patients with sleep apnoeaEuropean Respiratory Journal, 2000